IceCure Medical Ltd. revenue by segment ICCM
IceCure Medical Ltd. splits its revenue into 3 lines in its filings. The largest line in fiscal 2025, which ended Dec 31, 2025 was Disposables at $2.1 million, 61% of the total.
USD in millions. The percent under a figure is the change from the year before.
| Line |
FY 2025
Dec 31, 2025
|
FY 2024
Dec 31, 2024
|
FY 2023
Dec 31, 2023
|
FY 2022
Dec 31, 2022
|
FY 2021
Dec 31, 2021
|
|---|---|---|---|---|---|
| Revenue |
3
|
3
|
3
|
3
|
4
|
| Disposables |
2
+12.3%
share 60.8%
|
2
+21.6%
share 55.5%
|
2
+12.5%
share 46.5%
|
1
+10.6%
share 43.3%
|
1
share 29.2%
|
| Systems |
1
-2.7%
share 39.2%
|
1
-6.1%
share 41.4%
|
1
+44.9%
share 45.0%
|
1
-35.8%
share 32.5%
|
2
share 37.7%
|
| Exclusive Distribution Agreement |
—
|
0
-63.5%
share 3.0%
|
0
-63.3%
share 8.5%
|
1
-45.5%
share 24.2%
|
1
share 33.1%
|
How these figures are calculated
Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. More on our methodology.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- ICCM (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Israel
- Headquarters
- Caesarea
- SEC filer status
- Non-accelerated filer, Emerging growth company
- SEC CIK
- 1584371
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.